SNCE SCIENCE 37 HLDGS INC

Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”

Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”

Science 37’s Patient Recruitment Recognized in Prestigious International Annual Awards Program for Standout Digital Health & Medical Technology Products and Companies

RESEARCH TRIANGLE PARK, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- , today announced its selection as winner of the “Clinical Efficiency Innovation Award” in the 8th annual MedTech Breakthrough Awards program.

, an independent market intelligence organization, recognized Science 37 for its transformative solution to clinical research patient recruitment. By leveraging its nationwide medical licensure and AI-powered patient screening capabilities, Science 37’s Patient Recruitment solution engages, medically qualifies, and delivers fully consented participants to sites prior to their first study visit. This unique approach creates a better patient experience, increases patient randomization rates, improves site satisfaction, and nearly eliminates patients being redirected to competing studies.

“We understand the difficulty in turning referrals into consented participants and have worked hard to address these issues by revolutionizing the conventional approaches head-on,” said Erica Prowisor, SVP Patient and Site Networks at Science 37. “This award from MedTech Breakthrough highlights our work to mitigate the core challenges of conventional recruitment methods resulting in a win-win for sponsors and sites. We’ll continue to transform patient recruitment by delivering an improved process designed to increase enrollment and site/primary investigator productivity.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data & Privacy, and many more. This year’s program attracted thousands of nominations from over 18 different countries throughout the world.

“The ability to find, recruit, and enroll participants is a huge challenge for clinical trials, resulting in 80% of them being delayed, and the majority of participant referrals are not even fully qualified,” said Steve Johansson, Managing Director at MedTech Breakthrough. “By delivering fully consented and medically qualified participants directly to sites, sponsors, and CROs, Science 37 eliminates common issues of disengaged site staff and having referrals diverted to competing studies. Science 37's Patient Recruitment is more than a solution—it's a leap forward in clinical trial efficiency and innovation—and we’re thrilled to recognize the entire Science 37 team for taking home our ‘Clinical Efficiency Innovation Award’ in 2024.”

About MedTech Breakthrough



Part of , a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit . 

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

About Science 37

Science 37’s mission is to accelerate clinical research by enabling universal trial access for patients. Through our solutions; the Metasite™ and Patient Recruitment, we accelerate enrollment by expanding the reach of clinical trials to patients beyond the traditional site and rigorously qualifying patients prior to referring them to a traditional site. Our solutions are powered by a proprietary technology stack with in-house medical and operational experts that enhance quality through standardized workflows and best-in-class study orchestration. To learn more, visit , or email .

To view studies that Science 37 is actively recruiting for, please visit .

Media Inquiries



Science 37

 



EN
09/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SCIENCE 37 HLDGS INC

 PRESS RELEASE

Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Majo...

Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance Science 37’s Virtual Site Model for Clinical Research Impresses in First-of-its-Kind FDA Inspection RESEARCH TRIANGLE PARK, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- today announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation. The nearly two-week review included, but was not limited to, the Science 37 Metasite™ model and internal processes, technology utilized to support each trial, data integrity, efficacy...

 PRESS RELEASE

Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficien...

Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation” Science 37’s Patient Recruitment Recognized in Prestigious International Annual Awards Program for Standout Digital Health & Medical Technology Products and Companies RESEARCH TRIANGLE PARK, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- , today announced its selection as winner of the “Clinical Efficiency Innovation Award” in the 8th annual MedTech Breakthrough Awards program. , an independent market intelligence organization, recognized Science 37 for its transformative solution to clinical research patient r...

 PRESS RELEASE

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in ...

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial Partnership with Leading Biotech Company Enrolls 28% of Study Participants with 22x Greater Enrollment Velocity Compared to Traditional Brick-and-Mortar Clinical Trial Sites RESEARCH TRIANGLE PARK, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- today disclosed the latest enrollment figures resulting from its Metasite™ and Patient Recruitment partnership with a leading biotech company whose asthma drug is currently undergoing a Phase 3 clinical trial. Leveraging its proprietary Metasite™ and Pat...

 PRESS RELEASE

Science 37 Provides Fully Consented Patients to Sites to Supplement En...

Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment New patent-protected, central recruitment leverages the Science 37 Metasite™ to accelerate enrollment and dramatically reduce site burden RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., the clinical research industry’s leading MetasiteTM, today announced the launch of a stand-alone Patient Recruitment Solution to deliver patients to sites that are eligible, medically reviewed, and fully consented. While traditional central patient recruitment campaigns have prove...

 PRESS RELEASE

Science 37 to be Acquired by eMed, Expanding Access to Patients and Ac...

Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment Science 37 stockholders to receive $5.75 per share in cash RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading MetasiteTM, today announced that it has entered into a definitive merger agreement to be acquired by eMed, LLC (“eMed”), the leader in on-demand virtual care and treatment for consumers. With the most authoritative in-home testing and treatment solution available...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch